Betahistin-Mepha 16
Betahistin-Mepha 16 is a medicine authorised by Swissmedic under authorisation number 58124. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 October 2007 and the authorisation is valid without a time limit. ATC code N07CA01 places the medicine in the group Other nervous system drugs.
| Authorisation number | 58124 |
|---|---|
| Name | Betahistin-Mepha 16 |
| Full name | Betahistin-Mepha 16, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N07CA01 |
| First authorisation | 29 October 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Betahistin-Mepha 16, Tabletten | B | 29 October 2007 |
| 3 | Betahistin-Mepha 24, Tabletten | B | 29 October 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 50 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 3 | 100 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 5 | 50 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 7 | 100 | Tablette(n) | N07CA01 | 02.04.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Betahistin-Mepha 16 authorised in Switzerland?
Yes. Betahistin-Mepha 16 is authorised by Swissmedic under authorisation number 58124, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Betahistin-Mepha 16 have?
Betahistin-Mepha 16 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Betahistin-Mepha 16?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.